Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Assess the Feasibility of Centralizing Biological Samples at Onset and Relapse of Patients Referred to CROP Centers for Molecular Characterization of Oncohematologic Pathology

NCT06304194 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.

NCT NCT06304194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Assess the Feasibility of Centralizing Biological Samples at Onset and Relapse of Patients Referred to CROP Centers for Molecular Characterization of Oncohematologic Pathology
Lead sponsor
Meyer Children's Hospital IRCCS
Phase
Not applicable
Overall status
Recruiting
Start date
July 5, 2023
Completion date
July 5, 2028
Enrollment
340 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic diseases, oncologic disease